PT  - JOURNAL ARTICLE
AU  - van der Toorn, Wiep
AU  - Oh, Djin-Ye
AU  - von Kleist, Max
AU - on behalf of the working group on SARS-CoV-2 Diagnostics at RKI
TI  - COVIDStrategyCalculator: A software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
AID  - 10.1101/2020.11.18.20233825
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.11.18.20233825
4099  - http://medrxiv.org/content/early/2021/04/23/2020.11.18.20233825.short
4100  - http://medrxiv.org/content/early/2021/04/23/2020.11.18.20233825.full
AB  - While large-scale vaccination campaigns against SARS-CoV-2 are rolled out at the time of writing, non-pharmaceutical interventions (NPIs), including the isolation of infected individuals, and quarantine of exposed individuals remain central measures to contain the spread of SARS-CoV-2. Strategies that combine NPIs with innovative SARS-CoV-2 testing strategies may increase containment efficacy and help to shorten quarantine durations.We developed a user-friendly software-tool that implements a recently published stochastic within-host viral dynamics model that captures temporal attributes of the viral infection, such as test sensitivity, infectiousness and the occurrence of symptoms. Based on this model, the software allows to evaluate the efficacy of user-defined, arbitrary NPI and testing strategies in reducing the transmission potential in different contexts. The software thus enables decision makers to explore NPI strategies and perform hypothesis testing, e.g. with regards to the utilization of novel diagnostics or with regards to containing novel virus variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWvDT and MvK acknowledge funding from the Germany ministry for science and education (BMBF; grant numbers 01KI2016 and 031L0176A). D-YO acknowledges funding through the German ministry of health (BMG) as part of the COVID emergency crisis funds provided to RKI. The funders had no role in designing the research or the decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data for reproducing the results is available as outlined in the manuscript. https://github.com/CovidStrategyCalculator/CovidStrategyCalculator